欢迎访问《中国实验方剂学杂志》编辑部网站!
黄精多糖水解物柱前衍生HPLC指纹图谱
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

基金项目:

广东省部产学研结合项目(2012B090600025)


Pre-column Derivatives HPLC Fingerprint of Polygonati Rhizoma Polysaccharide Hydrolysate
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的: 建立黄精多糖柱前衍生HPLC指纹图谱. 方法: 以三氟乙酸(TFA)水解黄精多糖,水解产物加入1-苯基-3-甲基-5-吡唑啉酮(PMP)进行衍生化,采用HPLC测定单糖的衍生物.采用ZORBAX Eclipse XDB-C18色谱柱(4.6 mm×250 mm, 5 μm),流动相0.1 mol·L-1磷酸缓冲液(pH 6.7)-乙腈(84.5 :15.5),检测波长250 nm,柱温30 ℃,流速0.8 mL·min-1. 结果: 黄精多糖柱前衍生指纹图谱标示出10个共有峰,鉴别了7个共有峰(D-甘露糖, D-半乳糖醛酸, L-鼠李糖, D-半乳糖, D-葡萄糖, D-木糖, D-阿拉伯糖).10批黄精药材指纹图谱相似度 >0.99. 结论: 该方法简便,分离度高,重复性及稳定性良好,可有效控制黄精多糖的质量.

    Abstract:

    Objective: To establish a pre-column derivation HPLC method of chromatographic fingerprint of Polygonati Rhizoma polysaccharide. Method: Polygonati Rhizoma polysaccharide was hydrolyzed with trifluoroacetic acid and derivated by 1-phenyl-3-methyl-5-pyrazolone (PMP). The monosaccharide composition was separated by reversed-phase technique on a Zorbax Eclipse XDB-C18 column (4.6 mm×250 mm, 5 μm) with a mobile phase composed of 0.1 mol·L-1phosphate buffer (pH 6.7) and acetonitrile in the ratio of 84.5 : 15.5.The flow rate was 0.8 mL·min-1. The detection wavelength was set at 250 nm, and column temperature was at 30 ℃. Result: There were 10 common peaks from the fingerprint and 7 peaks were identified as D-mannose, L-rhamnose, D-galacturonic, D-galactose, D-glucose, D-xylose, and D-arabinose. The similarity of 10 batches of Polygonati Rhizoma polysaccharide was more than 0.99. Conclusion: The method is accurate and reproducible, which can be used for the quality control of Polygonati Rhizoma.

    参考文献
    相似文献
    引证文献
引用本文

秦垂新,曹子丰,黄绮敏,林伟斌.黄精多糖水解物柱前衍生HPLC指纹图谱[J].中国实验方剂学杂志,2015,21(11):65~68

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2014-06-05
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2015-05-28
  • 出版日期:

地址:北京东直门内南小街16号

邮编:100700

电话:010-84076882

E-mail:syfjx_2010@188.com

中国实验方剂学杂志 ® 2024 版权所有

技术支持:北京勤云科技发展有限公司